Skip to main content
. 2008 May 27;98(11):1824–1829. doi: 10.1038/sj.bjc.6604379

Table 1. Clinicopathological factors and MCAK mRNA expression in 120 colorectal cancers.

Factors High expression (%) (n=39) Low expression (%) (n=81) P- value
       
Age (mean±s.d.) 65.3±12.3 66.9±11.3 0.49
       
Gender
 Male 22 (56.4) 48 (59.3) 0.76
 Female 17 (43.6) 33 (40.7)  
       
Histological grade
 Well 15 (38.5) 29 (35.8) 0.78
 Others (moderately, poorly and mucinous) 24 (61.5) 52 (64.2)  
       
 
 
Tumour size
 <30 mm (small) 8 (20.5) 17 (21.0) 0.95
 ⩾30 mm (large) 31 (79.5) 64 (79.0)  
       
Serosal invasion
 Absent 26 (66.7) 59 (72.8) 0.49
 Present 13 (33.3) 22 (27.2)  
       
Lymph node metastasis
 Absent 14 (35.9) 53 (65.4) 0.0023*
 Present 25 (64.1) 28 (34.6)  
       
Lymphatic invasion
 Absent 22 (56.4) 53 (65.4) 0.34
 Present 17 (43.6) 28 (34.6)  
       
Venous invasion
 Absent 26 (66.7) 69 (85.2) 0.019*
 Present 13 (33.3) 12 (14.8)  
       
Liver metastasis
 Absent 33 (84.6) 73 (90.1) 0.38
 Present 6 (15.4) 8 (9.9)  
       
Peritoneal dissemination
 Absent 35 (89.7) 80 (98.8) 0.021*
 Present 4 (10.3) 1 (1.2)  
       
Dukes' classification
 A and B 13 (33.3) 51 (63.0) 0.0023*
 C and D 26 (66.7) 30 (37.0)  

s.d.=standard deviation.

*P<0.05.